๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Molecular prognostic factors in diffuse large B-cell lymphoma

โœ Scribed by Daniel Morgensztern; Izidore S. Lossos

Book ID
107531913
Publisher
Springer
Year
2005
Tongue
English
Weight
375 KB
Volume
6
Category
Article
ISSN
1527-2729

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prognostic models for diffuse large b-ce
Prognostic models for diffuse large b-cell lymphoma
โœ Annarita Conconi; Emanuele Zucca; Enrico Roggero; Francesco Bertoni; Augusto Ber ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views

Prognosis of DLCL patients is variable and associated with well-deยฎned risk factors. In the past decade several pretreatment variables have been incorporated into prognostic models to predict the death risk of individual patients. The International Prognostic Index (IPI), developed in an internation

Biomarkers of potential prognostic signi
Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma
โœ Grace Wu; Armand Keating ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 116 KB

## Abstract Diffuse large Bโ€cell lymphoma (DLBCL) is a biologically heterogeneous disease for which the current approach to treatment is only successful for 50% of patients. The prognostic value of various clinical and biological factors in predicting treatment outcome is discussed in this paper. A

Molecular heterogeneity of B-lineage dif
Molecular heterogeneity of B-lineage diffuse large cell lymphoma
โœ Gisella Volpe; Umberto Vitolo; Antonino Carbone; Cristina Pastore; Marilena Bert ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 948 KB

B-lineage diffuse large cell lymphoma (B-DLCL) arising de novo is chatacterized by a marked degree of clinical heterogeneity. To determine whether or not the clinical heterogeneity of de novo B-DLCL is reflected by heterogeneity in the molecular features of these tumors, we investigated the pattern